| Authors: |
Enjalbert F; Cell Biology and Cutaneous Research, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom., Dewan P; Cell Biology and Cutaneous Research, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom., Caley MP; Cell Biology and Cutaneous Research, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom., Jones EM; Cell Biology and Cutaneous Research, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom., Morse MA; Adaptive Immunity Research Unit, GlaxoSmithKline Medicine's Research Centre, Stevenage, United Kingdom., Kelsell DP; Cell Biology and Cutaneous Research, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom., Enright AJ; Department of Pathology, University of Cambridge, Cambridge, United Kingdom., O'Toole EA; Cell Biology and Cutaneous Research, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.; Centre for Inflammation and Therapeutic Innovation, Queen Mary University of London, London, United Kingdom.; Department of Dermatology, Royal London Hospital, Barts Health NHS Trust ERN-Skin, London, United Kingdom. |
